QNTM ▼ -0.6% - Quantum BioPharma Ltd.
$QNTM - Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
06-OCT-2026 06:00 AM ET
Share this post
More filings for $QNTM
QNTM - Quantum BioPharma Ltd. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 5, 2026QNTM ▲ +1.6% - Quantum BioPharma Ltd.Sep 17, 2026QNTM ▲ +1.7% - Quantum BioPharma Ltd.Sep 15, 2026QNTM ▲ +2.7% - Quantum BioPharma Ltd.Sep 11, 2026QNTM ▲ +3.1% - Quantum BioPharma Ltd.Sep 9, 2026$QNTM SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 8, 2026
View full $QNTM filing history →💬 Comments
Loading comments…
Leave a comment